Skip to main content

Schistosoma Species Protein Kinases

  • Living reference work entry
  • First Online:
  • 36 Accesses

Recently it was shown that protein kinases (PKs) control important biological processes in schistosomes as well as that other PKs are involved in the etiology of cancer. This led to the development of several anticancer drugs that inhibit deregulated PKs. Thus there are approaches to use these PKs-blockers as tentative new antischistosomal medicaments in future, if praziquantel should loose its activity against schistosomes.

This is a preview of subscription content, log in via an institution.

Further Reading

  • Dissous C, Grevelding CG (2011) Piggy-backing the concept of cancer drugs for schistosomiasis treatment: a tangible perspective. Trends Parasitol 27:59–66

    Article  CAS  PubMed  Google Scholar 

  • Knobloch J et al (2006) Herbimycin A suppresses mitotic activity and egg production of female Schistosoma mansoni. Int J Parasitol 36:1261–1272

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Heinz Mehlhorn .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer-Verlag Berlin Heidelberg

About this entry

Cite this entry

Mehlhorn, H. (2015). Schistosoma Species Protein Kinases. In: Mehlhorn, H. (eds) Encyclopedia of Parasitology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-27769-6_4885-1

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-27769-6_4885-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Online ISBN: 978-3-642-27769-6

  • eBook Packages: Springer Reference Biomedicine and Life SciencesReference Module Biomedical and Life Sciences

Publish with us

Policies and ethics